Hypoxia Enhances Platelet-derived Growth Factor Signaling in the Pulmonary Vasculature by Down-Regulation of Protein Tyrosine Phosphatases-Reference-Cited by-同舟云学术

Hypoxia Enhances Platelet-derived Growth Factor Signaling in the Pulmonary Vasculature by Down-Regulation of Protein Tyrosine Phosphatases

Published:2011-04-15 Issue:8 Volume:183 Page:1092-1102
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Freyhaus Henrik ten,Dagnell Markus,Leuchs Maike,Vantler Marius,Berghausen Eva M.,Caglayan Evren,Weissmann Norbert,Dahal Bhola K.,Schermuly Ralph T.,Östman Arne,Kappert Kai,Rosenkranz Stephan

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference48 articles.

1. Platelet-derived Growth Factor Expression and Function in Idiopathic Pulmonary Arterial Hypertension

2. Reversal of experimental pulmonary hypertension by PDGF inhibition

3. Gerasimovskaya EV, Tucker DA, Stenmark KR. Activation of phosphatidylinositol 3-kinase, Akt, and mammalian target of rapamycin is necessary for hypoxia-induced pulmonary artery adventitial fibroblast proliferation.J Appl Physiol2005;98:722–731.

4. Hypoxia exposure induces the emergence of fibroblasts lacking replication repressor signals of PKC in the pulmonary artery adventitia

5. Identification of the Receptor-associated Signaling Enzymes That Are Required for Platelet-derived Growth Factor-AA-dependent Chemotaxis and DNA Synthesis

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Classical dendritic cells contribute to hypoxia‐induced pulmonary hypertension;The FASEB Journal;2024-08-30

2. A novel PDGFR inhibitor WQ-C-401 prevents pulmonary vascular remodeling in rats with monocrotaline-induced pulmonary arterial hypertension;Experimental Cell Research;2024-08

3. Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial;The Lancet Respiratory Medicine;2024-07

4. Endothelial phosphodiesterase 4B inactivation ameliorates endothelial-to-mesenchymal transition and pulmonary hypertension;Acta Pharmaceutica Sinica B;2024-04

5. IMPAHCT: A randomized phase 2b/3 study of inhaled imatinib for pulmonary arterial hypertension;Pulmonary Circulation;2024-01